Headquartered in Indianapolis, Indiana, Eli Lilly and Company (LLY) researches, develops, and markets medicines across cardiometabolic disease, oncology, immunology, neuroscience, and beyond. With a ...

Eli Lilly advances CRISPR collaboration with Scribe Therapeutics for neurological and neuromuscular disorders; European ...

Eli Lilly operates in the healthcare sector as a global pharmaceutical manufacturer with commercial medicines and a broad research portfolio across immunology, oncology, and metabolic health. Eli ...

Eli Lilly and Company (NYSE:LLY) is included in the list of the best performing S&P 500 stocks in the last five years. As of ...

Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

Shares of Eli Lilly & Co. LLY slid 3.23% to $1,017.97 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.04% to 6,881.62 and the ...

Eli Lilly and Co. (NYSE:LLY) on Monday shared positive topline results from the Phase 3 LIBRETTO-432 clinical trial for ...

The pharmaceutical sector is highly competitive and driven by innovation. GLP-1 weight loss drugs are a perfect example. Novo Nordisk was first to market with a GLP-1 shot. Eli Lilly's GLP-1 shots ...

Eli Lilly and Company (NYSE:LLY) shares are up on Monday as the company benefits from positive market sentiment following ...

Shares of Eli Lilly & Co. LLY slid 1.28% to $1,028.83 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.81% to 6,946.13 and ...